US2002116735A1PendingUtilityA1

Nucleic acids encoding a plant enzyme involved in very long chain fatty acid synthesis

Assignee: UNIV BRITISH COLUMBIAPriority: Apr 14, 1997Filed: Jun 26, 2001Published: Aug 22, 2002
Est. expiryApr 14, 2017(expired)· nominal 20-yr term from priority
C12N 15/8223C12N 9/1029C12N 15/8222C12N 15/8289C12N 15/8247
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Nucleic acid molecules encoding an enzyme involved in very long chain fatty acid (VLCFA) elongation in plants are disclosed. The invention includes a cDNA, genomic clone and encoded protein, as well as plants having modified VLCFA composition, such as modified epicuticular waxes, and methods of making such plants.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . An isolated nucleic acid molecule that encodes a protein having very long chain fatty acid elongase activity, wherein the nucleic acid molecule is selected from the group consisting of: 
 (a) nucleic acids comprising at least 15 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 3;    (b) nucleic acids possessing at least 70% sequence identity with the sequence set forth in Seq. I.D. No. 3; and    (c) nucleic acids that hybridize under conditions of at least 70% stringency with the sequence set forth in Seq. I.D. No. 3.    
     
     
         2 . An isolated nucleic acid molecule according to  claim 1  wherein the nucleic acid molecule comprises the sequence set forth in Seq. I.D. No. 3.  
     
     
         3 . An isolated nucleic acid molecule according to  claim 1  wherein the nucleic acid molecule possess at least 80% sequence identity with the sequence set forth in Seq. I.D. No. 3:  
     
     
         4 . An isolated nucleic acid molecule according to  claim 1  wherein the nucleic acid molecule hybridizes under conditions of at least 80% stringency with the sequence set forth in Seq. I.D. No. 3.  
     
     
         5 . A purified protein encoded by a nucleic acid molecule according to  claim 1 .  
     
     
         6 . A recombinant vector comprising a nucleic acid molecule according to  claim 1 .  
     
     
         7 . A recombinant vector according to  claim 6  wherein the nucleic acid molecule is in reverse orientation relative to an adjacent promoter sequence of the vector.  
     
     
         8 . A transgenic plant comprising a recombinant vector according to  claim 6 .  
     
     
         9 . A transgenic plant comprising a recombinant vector according to  claim 7 .  
     
     
         10 . A transgenic plant comprising a recombinant expression cassette comprising a promoter sequence operably linked to a nucleic acid sequence selected from the group consisting of: 
 (a) nucleic acids comprising at least 15 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 1;    (b) nucleic acids possessing at least 70% sequence identity with the sequence set forth in Seq. I.D. No. 3; and    (c) nucleic acids that hybridize under conditions of at least 70% stringency with the sequence set forth in Seq. I.D. No. 3.    
     
     
         11 . A transgenic plant according to  claim 10  wherein the nucleic acid sequence comprises at least 30 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 1.  
     
     
         12 . A transgenic plant according to  claim 10  wherein the nucleic acid sequence possess at least 80% sequence identity with the sequence set forth in Seq. I.D. No. 3.  
     
     
         13 . A transgenic plant according to  claim 10  wherein the nucleic acid sequence hybridizes under conditions of at least 80% stringency with the sequence set forth in Seq. I.D. No. 3.  
     
     
         14 . A transgenic plant according to  claim 10 , wherein the plant has a modified phenotype compared to a non-transgenic plant of the same species.  
     
     
         15 . A transgenic plant according to  claim 14  wherein the modified phenotype is a modified very long chain fatty acid composition.  
     
     
         16 . A transgenic plant according to  claim 15  wherein the modified phenotype is a modified epicuticular wax layer.  
     
     
         17 . A transgenic plant according to  claim 14  wherein the modified phenotype is modified seed oil composition.  
     
     
         18 . A transgenic plant according to  claim 14  wherein the modified phenotype is conditional male sterility.  
     
     
         17 . A method of producing a plant with a modified very long chain fatty acid composition relative to a non-transgenic plant of the same species, comprising introducing into the plant a recombinant vector according to  claim 6 .  
     
     
         18 . A transgenic plant produced by the method of  claim 17 .  
     
     
         19 . A transgenic plant produced by sexual or asexual propagation of a plant according to  claim 18  or the progeny of said plant.  
     
     
         20 . An isolated nucleic acid molecule having a nucleotide sequence according to Seq. I.D. No. 3.  
     
     
         21 . An isolated nucleic acid molecule that encodes a protein having an amino acid sequence as shown in Seq. I.D. No. 4.  
     
     
         24 . A method of isolating a nucleic acid molecule encoding a plant very long chain fatty acid elongation enzyme, the method comprising hybridizing a nucleic acid preparation with a DNA molecule comprising at least 15 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 1.  
     
     
         25 . An isolated nucleic acid molecule isolated according to the method of claim  24 .  
     
     
         26 . A recombinant nucleic acid molecule comprising a promoter sequence operably linked to a nucleic acid sequence, wherein the promoter sequence comprises a CUT1 promoter.  
     
     
         27 . A recombinant nucleic acid molecule according to claim  26  wherein the promoter sequence comprises at least 50 consecutive nucleotides of the sequence shown in Seq. I.D. No.12.  
     
     
         28 . A purified peptide having an amino acid sequence that is at least 70% identical to the sequence set forth in Seq. I.D. No. 4.

Join the waitlist — get patent alerts

Track US2002116735A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.